COVID 19: UK coronavirus deaths rise 616, with another 12,282 positive tests | UK News



[ad_1]

The number of people dying from coronavirus in the UK in the last 24-hour period has risen by 616, while cases have risen by 12,282.

The death toll is a huge increase compared to 189 COVID-19-related deaths.

Sometimes there is a delay in reporting after the weekend.

The total number of people who have died in the 28 days after testing positive for the virus is now 62,033.

There were 14,718 cases registered yesterday.

The total number of people who tested positive for the virus in the past seven days has reached 107,158.

And since the pandemic began, 1,750,241 have been confirmed coronavirus infections in the UK.

Figures separated by statistical agencies where COVID-19 has been mentioned on the death certificate, along with additional data, show that there have been 78,000 coronavirus-related deaths in the UK.

Use the Chrome browser for a more accessible video player

By the time Margaret Keenan became Patient A

Meanwhile, the fight against COVID-19 has taken a historic leap after the Pfizer / BioNTech vaccine was first administered to people outside of a clinical trial.

Margaret Keenan, grandmother of four, who will turn 91 next week, became the first person in the world to receive the jab as part of a vaccination program.

Mrs Keenan, who has lived in Coventry for six decades but is originally from Eniniskillen, Northern Ireland, received the vaccine from Nurse May Parsons at the city’s University Hospital at 6.31am. M.

She said being her first was “a privilege” and “the best anticipated birthday gift she could wish for” as it would mean she could spend time with family and friends in the New Year “after being alone most of the year. “.

Subscribe to the daily podcast on Apple Podcasts, Google Podcasts, Spotify, Spreaker

Also in another impulse, the The University of Oxford / AstraZeneca vaccine is safe and effective, has confirmed an independent analysis.

Researchers say the jab will have a “great impact” on the pandemic.

The study, published in The Lancet, is the first peer-reviewed analysis to look at phase 3 data from a vaccine trial.

[ad_2]